Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AB Akola Group, ISIN code LT0000128092, (hereinafter - the Company), has received a notification from the person discharging managerial responsibilities regarding the transactions in the Company's...
-
At the initiative of and subject to the Decision of 25 March 2026 of the Board of AB Amber Grid (company code 303090867), registered office address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania...
-
The Annual General Meeting of Shareholders of AB “Ignitis grupė” (hereinafter – the Group), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, which was held on 25...
-
The Annual General Meeting of Shareholders of AB “Ignitis grupė” (hereinafter – the Group), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, which was held on 25...
-
Vilnius, Lithuania, March 25, 2026 (GLOBE NEWSWIRE) -- Hostinger, a no-code AI-powered online business growth platform, has made OpenClaw available in a one-click setup that runs immediately, with...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
#FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual...